-
441
Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
Published 2025-03-01Subjects: Get full text
Article -
442
The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study
Published 2025-01-01Subjects: Get full text
Article -
443
Thyroid Dysfunction following Radiotherapy and Combined Therapy in Non-Thyroid Head and Neck Cancers
Published 2023-12-01Subjects: Get full text
Article -
444
Colorectal cancer spectrum: From subtypes and epidemiology to oncotherapies
Published 2025-04-01Subjects: Get full text
Article -
445
Obstruction from Deflux leading to significant kidney function loss and chemotherapeutic challenges in pediatric Ewing sarcoma
Published 2025-01-01Subjects: Get full text
Article -
446
Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
Published 2025-02-01Subjects: “…chemotherapy-induced peripheral neuropathy…”
Get full text
Article -
447
MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
Published 2016-06-01Subjects: Get full text
Article -
448
MANAGEMENT OF SYNCHRONIC LARGE LIVER METASTASIS IN A NON-OCCLUSIVE COLON TUMOR
Published 2025-01-01Subjects: Get full text
Article -
449
Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy
Published 2025-01-01Subjects: Get full text
Article -
450
-
451
The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis
Published 2021-06-01“…The outcomes were defined as incidence of FN in the first cycle and among all cycles of chemotherapy using three different definitions for FN. …”
Get full text
Article -
452
Development and feasibility of an mHealth intervention for psychoeducational support of Nigerian women diagnosed with breast cancer undergoing chemotherapy: A pilot randomized controlled trial.
Published 2024-01-01“…Thirty women newly diagnosed with BC and undergoing chemotherapy were randomly assigned to an intervention or a control group. …”
Get full text
Article -
453
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial
Published 2025-02-01“…Abstract We aimed to evaluate the efficacy and safety of adding apatinib, to sintilimab and chemotherapy in the neoadjuvant treatment of early triple-negative breast cancer (TNBC). …”
Get full text
Article -
454
Influence of symptom burden on social alienation in lung cancer patients receiving chemotherapy: the chain mediating effect of perceived social support and positive psychological capital
Published 2025-02-01Subjects: “…Lung cancer chemotherapy…”
Get full text
Article -
455
-
456
Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases
Published 2019-01-01“…Before neoadjuvant chemotherapy, all three cases underwent loop transverse colostomy for symptomatic colonic obstruction. …”
Get full text
Article -
457
Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy
Published 2025-01-01Subjects: Get full text
Article -
458
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Published 2025-02-01“…Abstract This prospective, nonrandomized, open-label phase 2 trial (Chinese Clinical Trial Registry, ChiCTR2200061906) aimed to evaluate the effectiveness of adding the PD-1 antibody tislelizumab to perioperative chemotherapy in patients with locally advanced gastroesophageal junction adenocarcinoma (GEJA). …”
Get full text
Article -
459
-
460